Atracurium is indicated as an addition to general anesthesia to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgery or mechanical ventilation. Atracurium is a non-depolarizing neuromuscular blocking drug of the benzylisoquinolinium class.
Product details
Also Gives | Third Party Manufacturing,PCD Pharma Franchise |
Composition | Atracurium Besylate 50 mg |
Manufacturer | MITS |
Brand | Atracurium Besylate Injection 50 mg |
Packaging Size | 5x5 ml |
Prescription/Non prescription | Prescription |
![]() |
MITS HEALTHCARE PRIVATE LIMITED
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |